ONE-WAYOngoing theme · still written in the latest filings
US Phase 1/2 clinical development of CTX-712 for hematologic cancers
A standalone development topic covering the US Phase 1/2 clinical trial of CTX-712 in patients with hematologic cancers, with the aim of initiating a Phase 2 trial through patient enrollment and transition to an expansion cohort.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.